Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
Clinical trial NCT04393441 · COMPLETED
Trial details
- NCT number
- NCT04393441
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-29
- Primary completion
- 2021-06-15
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.